Long-term stability testing of gene therapy formulations refers to the stability study of a formulation under actual storage conditions to determine the product's expiration date and storage conditions to ensure that it remains safe, effective and stable during its expiration date. Therefore, long-term stability testing of gene therapy formulations is of great significance, and this testing is crucial to the development of gene therapy formulations.
CD Formulation provides clients with accurate, reliable and long-term stability testing of gene therapy formulations to help researchers ensure that data on production, storage and transportation conditions are available for gene therapy formulation development, as well as to provide theoretical support for quality standards for gene therapy formulations.
Long-term stability testing can help developers understand the stability characteristics of a product, including sensitive conditions, degradation pathways, and degradation rates, and can also help assess any changes that may occur to a gene therapy formulation during storage, ensuring that the final product always meets quality standards.
We do this by assessing whether the formulation will precipitate, aggregate, denature, or undergo other physicochemical changes during storage. Examples include observing changes in color, clarity, precipitates or delamination of the formulation. Evaluate changes in pH during storage for stability, biocompatibility, etc.
This process mainly entails testing whether the formulation maintains its intended biological activity and potency during storage. For example, by viral titer or gene load analysis, the expression level of genes in the vector or changes in load are determined. By transduction efficiency assay, to test whether the vector can effectively express the target gene after entering the cell, to assess its loss of activity during storage, etc.
To test whether the preparation is contaminated by microorganisms. We mainly perform sterility testing as well as testing for endotoxin levels, which is used to ensure that the preparation remains sterile throughout the storage period.
For viral vectors, attention is paid to the genetic stability of viral vectors during storage, transportation and use, including changes in viral vector titer, infection titer, aggregation and biological activity.
For nucleic acid-based products, we need to assess their integrity and stability during storage, especially for RNA-based products, we need to focus on their sensitivity to RNA enzymes.
This process tests whether the formulation will produce protein aggregation or other changes that lead to an immune response during storage and is used to assess whether the formulation will produce unintended immunogenicity during storage.
Fig.2 Our service for gene therapy formulation long-term stability testing. (CD Formulation)
Equipment and Instruments | ||
---|---|---|
Next generation sequencing (NGS) | Quantitative PCR (qPCR) | Flow cytometry |
Enzyme-linked immunosorbent assay (ELISA) | High performance liquid chromatography (HPLC) | Dynamic light scattering (DLS) and multi-angle light scattering (MALS) |
Bio-safety cabinets | Learn more |
Technology: Gene therapy formulation stability testing
Journal: Pharmaceutics
IF: 5.4
Published: 2024
This study focuses on developing effective nano-carriers for delivering therapeutic miRNA, specifically miR-375, to treat Hepatocellular carcinoma (HCC). Two new cationic nanostructured solid/liquid lipid carriers (NSLCs) were developed and improved to deliver miR-375 into HCC cells. These NSLCs were coated with varying amounts of chitosan (CS). The physical stability, conjugation efficiency, and capacity to shield miR-375 from serum degradation were evaluated for these carriers (F1 and F2). According to the study, both carriers showed low toxicity, sustained long-term stability, and effectively transported miR-375; nevertheless, F2 had better anti-tumor effects when compared to both free miR-375 and doxorubicin (DOX). The findings imply that these NSLCs have demonstrated strong therapeutic efficacy and medication stability.
CD Formulation provides reliable and accurate long-term stability testing services for gene therapy formulations, relying on our advanced technology platform and years of service experience. The testing we provide is essential to ensure the quality and performance of gene therapy formulations throughout their life cycle, and it is of great significance to the formulation's development. If you are interested in us, please feel free to contact us.
References